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Prostaglandins (PGs) can modulate a variety of renal functions, 
including Na’ and Cl- reabsorption. However, it is not known 
if a direct interdependence exists between PG synthesis and 
transport activity. The present study was done to find out 
whether or not the rate of NaCl transport has an influence on 
PG synthesis in renal tubular cells. For our studies we used 
cultures of so-called high-resistance MDCK cells, which were 
originally derived from canine kidney. This cell type has a loop 
diuretic- and ouabain-sensitive NaCl transport that can be 
enhanced by activation of the adenylate cyclase (AC). In 
MDCK cell cultures we found that each state of increased NaCl 
transport during stimulation of AC by either epinephrine (lo-” 
M), isoprenaline ( low5 M), or forskolin ( lOa M) was accom- 
panied by a twofold increase in PG release. During inhibition 
of NaCl transport by furosemide ( 10B4 M) or ouabain (2 X low4 
M), stimulation of AC failed to increase PGEz release, whereas 
basal PG production was not inhibited by either furosemide or 
ouabain. Furthermore, PG formation during activation of AC 
was dependent on the concentration of extracellular Na’, 
whereas PG formation in the absence of activators of AC was 
independent of extracellular Na’. These results suggest that 
increased NaCl transport stimulates PG formation in cultures 
of high-resistance MDCK cells. 
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THERE IS SOME EXPERIMENTAL EVIDENCE indicating 
that an increased NaCl load to the kidney is capable of 
enhancing the release of renal prostaglandins (PGs) (13, 
18, 22). Because PGs have been found to have a natri- 
uretic effect on the kidney (cf. 5, 6), an increased renal 
PG release during increased NaCl load could be of phys- 
iological importance for the Na+ homeostasis of the 
organism (24). The mechanism by which a NaCl load 
could stimulate renal PG release in the kidney is, as yet, 
unclear. Assuming that increased renal NaCl load implies 
enhanced NaCl delivery to renal tubular cells and in 
consequence enhanced NaCl transport by tubular cells, 
it may be hypothesized that increased PG synthesis could 
be linked to enhanced tubular NaCl transport. We were 
therefore interested in finding out whether or not an 
increase in NaCl transport is capable of stimulating PG 
synthesis in a renal epithelial cell. For this study we used 
cultures of high-resistance MDCK cells, a substrain of 
MDCK cells (1, 15). MDCK cells have been derived from 
canine kidney and these cells have been found to share 
functional and structural similarities with renal tubular 
cells (16, 20). Moreover, high-resistance MDCK cells 
were shown to possess a furosemide- and ouabain-sensi- 
tive NaCl transport that can be stimulated by activation 
of the adenylate cyclase (3, 21). We found in this study 
that each state of enhanced NaCl transport was accom- 
panied by enhanced PG formation. Moreover, we ob- 
tained clear evidence for a causal link between increased 
NaCl transport and enhanced PG formation. 
MATERIALS AND METHODS 
Cell culture. MDCK cells (60-72 serial passage) were 
obtained from Flow, Irvine Scotland. Cells were grown 
on Petri dishes or on Millipore filters (1) in a humidified 
atmosphere containing 10% CO2 in air. Compositions of 
culture media are listed below. 
ELectricaL measurements. Electrical measurements 
were made as described in Ref. 3. Briefly, cell monolayers 
grown on Millipore filters were mounted in Ussing cham- 
bers (0.75cm window radius, 1.76 cm2 exposed mono- 
layer area) thermostatically controlled at 37°C for mea- 
surement of potential difference and resistance. An au- 
tomatic voltage clamp was connected to the chamber via 
matched calomel half-cells, Ag-AgCl half cells, and sat- 
urated KC1 salt bridges. Resistance measurements under 
open-circuit conditions were made by passing ~-PA hy- 
perpolarizing current pulses across the cell monolayer 
and measuring the subsequent voltage deflection. The 
experiments were carried out in buffer 1 (see below). 
PGE2 release. PGE2 release was determined using sub- 
confluent cultures grown in Petri dishes or confluent 
cultures grown on Millipore filters. For determination of 
PGE2 release of cells grown in dishes, cultures were 
washed twice with L-15 medium (Boehringer). At the 
onset of the experiments, 1 ml of fresh L-15 medium 
with or without agents was added followed by a 5-min 
incubation. For the experiments in which the effect of 
NaCl was investigated, buffers 2, 3, and 4 (see below) 
were used instead of L-15 medium. Medium or buffers 
were withdrawn, frozen in liquid nitrogen, and stored at 
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-80°C until assay for PGE2. For determination of PGEz 
release from cells grown on Millipore filters, the filters 
were mounted in a perfusion chamber (~011 ml) in which 
the perfusate had access to both the basal and apical 
membranes of the cells. Filters were perfused with L-15 
medium at a rate of 5 ml/min. One-minute samples were 
frozen and stored at -80°C until assay for PGEZ. PGEz 
concentrations were determined by radioimmunoassay 
for PGE2 (New England Nuclear). For protein determi- 
nation, cells were lysed in 0.5 M NaOH, and protein was 
determined according to the method of Lowry et al. (12). 
Determination of pattern of released PG. Cells were 
labeled with 5 &i/ml [3H]arachidonic acid (Amersham) 
for 24 h. Medium was removed, and cells were washed 
twice with L-15 medium containing 0.3 mg/ml fatty acid- 
free bovine serum albumin (Sigma Chemical). Then 1 ml 
of L-15 medium with or without agents was added. Me- 
dium was removed after 5 min. PGs were extracted from 
the medium using columns of octadecylsilyl-silica (10 X 
10 mm, Sep Paks, Waters Associates) as described by 
Ref. 14. PGs were separated by high-pressure liquid 
chromatography (HPLC) using an Ultropak prepacked 
column (LichroSorb RP-18, 5 pm, 4 X 250 mm) and 
precolumn (LKB). PGs were eluted isocratically with 
0.1% acetic acid:acetonitril (64:36, vol/vol). Retention 
times determined with PG standards were 4.06,8.10, and 
9.97 min for 6-keto PGF1,,, PGF2,, and PGE2, respec- 
tively. Eluted radioactivity was counted in a P-scintilla- 
tion counter using Aquasol- (New England Nuclear). 
O2 consumption measurements. 02 consumption rates 
were determined in a commercial Gilson chamber (vol 
1.5 ml) with a Clark O2 electrode thermostated at 37°C. 
As incubation medium, buffer 2 (see below) was used. 
The chamber has been equilibrated with air, and exper- 
iments were started by the addition of cell suspension. 
After linear decrease of the 02 tension was reached, 
forskolin, furosemide, or ouabain was added to the cham- 
ber in a small volume (50 ~1 max) through a fine channel 
using a Hamilton syringe. After the experiments, the 
cells were pelleted using an Eppendorf centrifuge and 
lysed in 0.5 M NaOH for protein determination according 
to Lowry et al. (12). 
Chemicals and composition of media and buffers. PG 
standards, epinephrine, isoprenaline, furosemide, and 
ouabain were purchased from Sigma Chemical. Forskolin 
was from Hoechst, FRG. The solvent system for HPLC 
was obtained from Merck (FRG). 
Culture media. Dulbecco’s Modified Eagle’s medium 
(high glucose) and 10% fetal bovine serum were from 
Flow. Penicillin (100 U/ml), streptomycin (100 pg/ml), 
4 mM glutamine, and nonessential amino acids (1:lOO) 
were also used. Buffer 1 (in mM): 137 NaCl, 5.4 KCl, 2.8 
CaC12, 1.2 MgSO,, 0.3 NaH2P04, 0.4 KH2P04, 12 HCl, 
12 tris( hydroxymethyl)aminomethane base, 10 glucose, 
2% vol/vol donor horse serum; buffer 2 (in mM): 134 
NaCl, 5 KCl, 2 CaC&, 1 MgCl,, 1 MgC12, 10 glucose, 10 
N- 2 - hydroxyethylpiperazine -N’ - 2 - ethanesulfonic acid 
(HEPES), pH 7.3; buffer 3 ( in mM): 4 NaCl, 130 choline 
chloride, 5 KCl, 2 CaC12, 1 MgCl,, 10 glucose, 10 HEPES, 
pH 7.3; buffer 4 (in mM): 134 methylglucamine, 120 HCl, 
5 KCl, 2 CaCIZ, 1 MgC1,, 10 glucose, 10 HEPES, pH 7.3. 
RESULTS 
The transport characteristics of high-resistance 
MDCK cells have already been studied in great detail 
(cf. Ref. 21). It has been demonstrated that activation of 
the adenylate cyclase (AC) enhances short-circuit cur- 
rent (SCC) by increasing the Cl- conductance in the 
apical membrane of high-resistance MDCK cells. To 
ensure that the cell preparation we used had in fact the 
known transport characteristics, we tested the influence 
of epinephrine (low6 M) in the presence and absence of 
furosemide (10B4 M) on SCC and transepithelial resist- 
ance of the cultured MDCK cells grown on filters. Figure 
1 shows that epinephrine stimulated SCC and reduced 
transepithelial resistance. Furosemide caused a rapid 
inhibition of the epinephrine-stimulated SCC but had 
little effect on the epinephrine-stimulated conductance. 
We then determined the PGEZ releasing rate of sub- 
confluent cultures of MDCK cells grown in Petri dishes 
in the presence of epinephrine (10B6 M), isoprenaline 
( 10B5 M), and forskolin ( low5 M). These agents are known 
to stimulate a furosemide-sensitive NaCl transport in 
MDCK cells by activating the AC (17, 21). Figure 2 
shows that in the presence of epinephrine, isoprenaline, 
and forskolin the PGE, releasing rate was enhanced by 
a factor of about two. Furthermore, it is evident that 
furosemide (10B4 M) prevented this rise in PGEZ release, 
whereas furosemide itself had no inhibitory effect on 
basal PGE2 release. 
To gain information about the time kinetics of PGEz 
formation in the presence of forskolin and furosemide, 
we superfused confluent monolayers of MDCK cells 
grown on filters and assayed PGEZ production in consec- 
utive 1-min samples. Figure 3 shows the results of a 
typical superfusion experiment. It can be seen that ad- 
dition of forskolin (10V5 M) led to an immediate rise in 
PGEz release. Successive addition of furosemide (10B4 
M) led to a subsequent fall in PGEz formation to control 
values. Removal of furosemide from the superfusate in 
the continued presence of forskolin resulted in an im- 
mediate rise in PGEz formation, indicating that the 
inhibitory effect of furosemide was fully reversible. Re- 
moval of forskolin from the superfusate resulted in a 
decrease in PGEz formation to control values with a 
delay of 2 min. 
If the enhanced rate of PG release is in fact due to a 
stimulated transport rate of NaCl, then replacing Na’ 
by choline or methylglucamine should prevent the rise 
in PG release in response to forskolin. Removal of Na+ 
is known to inhibit NaCl movement across this epithe- 
lium, since uphill Cl- movement across the basolateral 
membrane through the Na+-K’-2Cl- cotransport mech- 
anism is highly Na+ dependent (3, 4). Figure 4 shows 
that the basal PGEz release was not dependent on the 
concentration of Na+. The stimulatory effect of forskolin, 
however, was clearly found to be dependent on the con- 
centration of extracellular Na+. 
It is known that inhibition of the Na+-K’-ATPase by 
ouabain also inhibits NaCl transport in MDCK cells (3, 
19). We therefore tested the effect of this compound on 
PGE2 formation in the presence and absence of forskolin 
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were added as indicated by arrows. Data are means & 
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FIG. 2. Effect of epinephrine, isoprenaline, and forskolin on PGE, 
release by high-resistance MDCK cells in the absence (open. bars) and 
presence (striped bars) of furosemide (lo-* M). Data are means & SEM 
of 6 experiments. 
( 10v5 M). It can be seen in Fig. 5 that ouabain itself had 
a significant stimulatory effect on basal PGEg release. 
The stimulatory effect of forskolin, however, was absent 
in the presence of ouabain. 
To find out whether or not the stimulation of NaCl 
transport by forskolin favored the release of PGE2 only 
or that of other prostaglandins as well, we determined 
the pattern of main prostanoid metabolites (8, 11) of 
[ 3H] arachidonic acid in the supernatants of subconfluent 
high-resistance MDCK cells. By using HPLC, we found 
a pattern of incorporated radioactivity of l:O.l5:0.04 for 
PGE2, 6-keto PGF1,, and PGF2,, respectively, after stim- 
ulation with forskolin. The pattern for cells in the ab- 
sence of forskolin was 1:0.13:0.04. Experiments were 
repeated twice. The variation coefficient between the 
experiments was 4%. 
DISCUSSION 
This study was designed to find out whether or not 
NaCl transport has any effect on PG release in high- 
resistance MDCK cells. Under nonstimulated condi- 
tions, MDCK cells show low transport activities of Na+ 
and Cl- ions and generally have a small net NaCl ab- 
sorption. Stimulation of AC by various agents (epineph- 
rine, isoprenaline or forskolin) results in a net rheogenic 
secretion of Cl- ions, which, under open-circuit condi- 
tions, will be accompanied by a similar movement of 
Na+. NaCl secretion is achieved as the result of the uphill 
movement of Cl- across the basolateral membrane 
through a Na+-K+-ZCl- cotransport mechanism that is 
inhibitable by the loop diuretic furosemide and is de- 
pendent on a functioning Na+-K+-ATPase to maintain 
a favorable Na+ gradient. At the apical membrane, Cl- 
is thought to exit the membrane down its electrochemical 
gradient via a gated Cl- channel (10). Our findings (Fig. 
1) that epinephrine greatly enhanced SCC and reduced 
transmembrane resistance is in agreement with previous 
results and indicates that the cell preparation we used 
had the well-documented transport characteristics. Fur- 
thermore, we found that furosemide caused a rapid in- 
hibition of the epinephrine-stimulated SCC but had little 
effect on the epinephrine-induced conductance in the 
apical membrane, implying that furosemide inhibited Cl- 
secretion by inhibiting the entry of Cl- into the cell and 
not by blocking an apically induced conductance. This 
finding also confirms previous results and indicates that 
the stimulated NaCl transport can be blocked by furo- 
semide (17, 21). 
We obtained three lines of evidence to indicate that 
NaCl transport stimulates PG formation in these cells. 
First, each state of increased NaCl transport during 
stimulation of AC by either epinephrine, isoprenaline, or 
forskolin was accompanied by an increased PGE2 release 
(Fig. 2). The possibility cannot be ruled out that epi- 
nephrine could have stimulated PG synthesis via cyl- 
adrenoreceptors (7). Well-defined activators of the AC, 
I- 
i- 
NACL TRANSPORT STIMULATES PROSTAGLANDIN RELEASE C679 
Control 1 Forskolin ~Forskolin(lO%A)~ Forskolin 1 Control 1 
(lo-5M) Furozemide (lo-%l~ 
(l(r4M) 
0 
\ /ON 
~ b 
FIG. 3. PGEz release of confluent cul- 
tures of high-resistance MDCK cells 
during superfusion. Forskolin and furo- 
semide were added to perfusion buffer as 
0 indicated in figure. Perfusate was col- 
lected in l-min samples. 
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FIG. 4. Effect of Na+ concentration on PGE2 release from high- 
resistance MDCK cells in the presence and absence of forskolin. For 
experiments done in the absence of Na+, buffer 4 was used, and in the 
presence of 4 mM Na’ buffer 3 (see MATERIALS AND METHODS) was 
used. Data are means & SE of 6 experiments. 
such as isoprenaline and forskolin, however, are unlikely 
to stimulate PG formation directly. In contrast, it has 
been shown that adenosine 3’,5’-cyclic monophosphate 
(CAMP) impairs PG formation by inhibiting both phos- 
1 
Control Ouabain 
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FIG. 5. Effect of ouabain on PGE, release from high-resistance 
MDCK cells in the absence (open bars) and presence (striped bars) of 
forskolin (10s5 M). Data are means _t SE of 6 experiments. 
pholipase A and cyclooxygenase in MDCK cells (9). A 
second line of evidence for an interdependence between 
NaCl transport and PG formation is the finding that 
inhibition of NaCl transport by furosemide and ouabain 
prevented the rise in PG release induced by activation 
of the AC (Figs. 2 and 5). The inhibitory effect of 
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TABLE 1. O2 consumption of high-resistance MDCK 
cells during stimulated and inhibited NaCl transport 
Condition 
O2 Consumption, 
,~l 02-h-‘-mg 
protein-’ 
Control 
Forskolin (low5 M) 
Forskolin (10s5 M) 
+ furosemide (10m4 M) 
Forskolin (lo-” M) 
+ ouabain (2 x 10s4 M) 
Values are means t SE of 3 experiments. 
18.0t1.2 
38.2k4.1 
17.7t1.9 
15.7k3.4 
furosemide on PG release was fully reversible (Fig. 3), as 
is its effect on NaCl transport (3,4). Moreover, we found 
that furosemide and ouabain had no inhibitory effect on 
basal PGEz release, ruling out a general inhibition of PG 
formation by these agents. The finding that ouabain led 
to a significant increase in PG formation is most likely 
due to the enhanced transmembrane influx of Ca2+ (2). 
A third piece of evidence implicating a connection be- 
tween NaCl transport and PG formation is our finding 
that the enhancement of PG release by stimulators of 
NaCl transport was clearly dependent on the extracel- 
lular concentration of Na’, whereas basal PG release was 
not (Fig. 4). Moreover, we found that in the absence of 
Na’ activation of AC had an inhibitory effect on PG 
formation (Fig. 4). This finding is in agreement with the 
results of Hassid (9), who has clearly shown that acti- 
vation of AC inhibits PG formation in low-resistance 
MDCK, which have a small NaCl transport that cannot 
be stimulated by CAMP (1). 
In summary, we conclude from the results discussed 
above that enhanced NaCl transport stimulates PG for- 
mation in MDCK cells. The mechanism by which NaCl 
transport could stimulate PG formation is not clear yet. 
From the finding that the pattern of PG produced, which 
is very similar to that observed by Hassid (8) and Lewis 
and Spector (ll), was not changed during enhanced 
transport, we conclude that the release of arachidonic 
acid, which is the rate-limiting step of PG formation, is 
enhanced during stimulated NaCl transport. Further- 
more, we found that stimulation of NaCl transport by 
epinephrine ( low6 M) and forskolin (lOa M) led to a 
twofold increase in O2 consumption, which could be 
prevented by furosemide ( 10m4 M) and ouabain (2 x 10B4 
M) (Table 1). Furthermore, in a previous set of experi- 
ments we obtained clear evidence that hypoxia, which is 
known to stimulate PG formation in the kidney (23), is 
also capable of stimulating PG synthesis two to threefold 
in cell cultures of high-resistance MDCK cells (unpub- 
lished results). In view of these findings, one could spec- 
ulate that enhanced NaCl transport causes a kind of 
intracellular hypoxia via enhanced 02 consumption. The 
mechanisms by which enhanced NaCl transport and 
hypoxia lead to an enhanced release of arachidonic acid 
are currently under investigation in our laboratory. 
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